NCT07573553 Effectiveness of Rib Mobilization Combined With Postural Correction Exercises in Individuals With Upper Crossed Syndrome
| NCT ID | NCT07573553 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Upper Cross Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-10-16 |
| Primary Completion | 2026-06-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-10-16 with a primary completion date of 2026-06-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of rib mobilization combined with postural correction exercises in reducing pain, improving cervical posture, and enhancing rib and thoracic mobility among individuals with Upper Crossed Syndrome (UCS). A total of 64 participants aged 20-45 years will be recruited and randomly assigned to two groups: Group A (rib mobilization + postural correction) and Group B (postural correction only). Intervention will be provided for 4-6 weeks, three sessions per week. Outcomes will include pain (VAS), cervical posture (inclinometer), and rib/thoracic mobility (tape measure). Data will be analyzed using SPSS version 26.
Eligibility Criteria
Inclusion Criteria: * Age between 20 to 45 years * Forward head posture (craniovertebral angle \< 50°) * Cervical pain or discomfort for ≥4 weeks * Moderate pain intensity (VAS 3-6) * Willingness to participate and provide informed consent * Clinically diagnosed Upper Crossed Syndrome (UCS) * Meets Asian Fitness Society diagnostic criteria for UCS Exclusion Criteria: * History of trauma or surgery to cervical/thoracic spine * Cervical disc herniation, radiculopathy, or neurological deficits * Structural deformities (scoliosis, Scheuermann's disease) * Systemic musculoskeletal disorders (e.g., rheumatoid arthritis) * Vestibular, balance, or visual disorders * Recent similar therapy within 3 months * Pregnancy or contraindication to manual therapy * Ongoing use of pain medications or muscle relaxants
Contact & Investigator
Attiq Ur Rehman, MS
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07573553 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Upper Cross Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07573553 currently recruiting?
Yes, NCT07573553 is actively recruiting participants. Contact the research team at altamash.hussain1@icloud.com for enrollment information.
Where is the NCT07573553 trial being conducted?
This trial is being conducted at Chak Six Hundred Twenty-four, Pakistan.
Who is sponsoring the NCT07573553 clinical trial?
NCT07573553 is sponsored by Riphah International University. The principal investigator is Attiq Ur Rehman, MS at Riphah International University. The trial plans to enroll 64 participants.